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Abstract
Background Cystic ﬁbrosis (CF) is one of the most common life-
threatening genetically inherited conditions and prenatal screening
for CF is available in many countries. Genetic counsellors and
other health professionals are expected to provide information
about the condition in a way that facilitates personal decision
making. Knowing what information to deliver about complex
genetic conditions to support informed screening decisions can be
challenging for health professionals.
Objective To solicit views from those with personal experience
with CF on which aspects of the condition they consider most
important to include in prenatal screening materials.
Methods Q-methodology; an approach to systematically explore
variations in viewpoint that combines factor analytic techniques
with qualitative approaches to pattern interpretation. Setting and
Participants: Twelve adults with CF and 18 parents of aﬀected
children were recruited from a regional centre in the UK.
Results Five distinct viewpoints on the items most and least impor-
tant to include in screening information were identiﬁed: Factor 1 the
normality of life with CF and increasing life expectancy; Factor 2
the hardships and reduced lifespan. Factor 3 medical interventions
and the importance of societal support. Factor 4 longer-term conse-
quences of CF. Factor 5 the ability to adjust to the condition.
Discussion The identiﬁcation of ﬁve diﬀerent views on what repre-
sented the most and least important information to include about
CF highlights the challenge of portraying a complex genetic condi-
tion in a balanced and accurate manner. Novel ways in which
Q-methodology ﬁndings can be used to meet this challenge are
presented.
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Introduction
Information provided via prenatal or genetic
testing services is intended to help pregnant
women, and their partners make informed deci-
sions about their testing options.1,2 Many pro-
spective parents have had little personal
experience with the conditions for which testing
is available, and health-care services are fre-
quently the sources of information on these
conditions. However, it has been recognized
that delivering balanced information about
complex genetic conditions such as cystic ﬁbro-
sis (CF) to facilitate informed decision making
is challenging for health professionals.3
Cystic ﬁbrosis is one of the most common
life-threatening genetically inherited conditions
aﬀecting Caucasians: around 1 : 25 people are
carriers of a CF gene mutation, and there is an
incidence of 1/2500 births.4 CF is a chronic,
multiorgan disease characterized by frequent
respiratory infections, bronchiectasis, male
infertility and pancreatic malabsorption. Life
expectancy is signiﬁcantly reduced, and current
median predicted survival is approximately
34 years for those living in countries with
access to appropriate health care.5 Survival
continues to improve, however, and babies
born today with CF have a life expectancy
over 50 years.6,7 Routine newborn screening
for CF has played an important role in earlier
access to treatment and management, but
whether this directly translates into a reduction
in child deaths is uncertain.8 New approaches
to treatment for CF, for example stem-cell and
gene therapies, continue to be sought but cur-
rently do not impact on life expectancy assess-
ments.9 However, there is much promise of
treatments that are speciﬁc to the gene muta-
tion, which do address the underlying genetic
defects.10 Despite such progress, for many
people with CF survival is still dependent on
frequent hospitalization, and a lifetime regimen
of medication and therapies that are time-
consuming and arduous.
Prenatal testing for CF takes a variety of
forms. Carrier screening for CF (testing asymp-
tomatic individuals to see if they carry a copy
of a known gene mutation) is available in
many countries although health policies vary
on how and to whom it is oﬀered.11 In the
United States, for example, practice standards
state that all Caucasian couples be oﬀered CF
carrier testing as part of pre-conceptual or pre-
natal care.12 In contrast, the UK does not rou-
tinely screen for CF carriers during pregnancy
unless there is a history of CF or there has
been identiﬁcation of risk factors, such as echo-
genic bowel via ultrasound scanning. CF is a
recessive genetic condition and when carrier
testing reveals that both parents carry a known
mutation the mother is oﬀered invasive diag-
nostic testing. Following a positive diagnosis
(and in those countries where termination of
pregnancy is permitted), parents are oﬀered a
choice whether to continue the aﬀected preg-
nancy. Up-to-date and balanced information
about CF, for example, clinical features, medi-
cal management and life expectancy is impor-
tant to understand when making an informed
choice about prenatal testing.13
Parents value and use information about the
impact of a genetic condition on quality of life
(QoL) in their prenatal testing decisions.14–16
Parents without direct knowledge of a condi-
tion will consider second-hand experiential
information in their prenatal testing decisions,
yet such information, including that from pro-
viders, may be biased or incomplete.17
Research shows that knowledge about QoL in
relation to CF is frequently low in couples
undergoing prenatal carrier screening for the
condition11 and that increasing such knowledge
aﬀects attitudes towards testing.17 Providing
balanced and accurate information is therefore
important for informed test decision making,
but there are a number of speciﬁc challenges
associated with developing balanced informa-
tion about a complex condition such as CF.
One is that variations in genotype and the role
of other modiﬁer genes lead to wide phenotypic
variability. In addition, environmental factors
and adherence to treatment impact on the
severity of the condition. Quality of life for
people with CF is very diﬃcult to predict as
perceptions vary not only with disease stage
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and severity, but also by individual factors
such as life stage and gender. 18
One study that considered the issue of bal-
anced information provision in CF carrier-test-
ing leaﬂets identiﬁed that in comparison with
leaﬂets aimed at screening a non-pregnant pop-
ulation, information about the condition in
prenatal testing information was more negative
in tone. 19 The authors suggested that a ‘rela-
tively equitable proportion’ of ‘negative’, ‘neu-
tral’ and ‘positive’ information statements
should be used to construct a balanced account
of CF in prenatal testing materials. For exam-
ple, (negative) information about reduced life-
span should be balanced with (positive)
information about treatment developments for
CF. However, it is argued that balanced infor-
mation is not simply that which presents equal
amounts of ‘bad’ and ‘good’ news. A diﬀerent
approach has been inﬂuenced by calls for pre-
natal testing information to incorporate knowl-
edge from those with direct experience of living
with the condition as a way of counterbalanc-
ing the (more negative) medical viewpoint.20,21
Incorporating experiential knowledge into all
types of prenatal testing information introduces
its own challenges as perceptions of what is a
balanced account of a condition vary.22 Health
professionals delivering prenatal testing in the
UK for example are situated in a position of
inherent tension as they are required to provide
information that both supports reproductive
autonomy and represents disability in a way
that does not negatively impact on the status
of people who have the conditions.23 It has
been argued that prenatal testing and abortion
is a problematic way for society to deal with
those who have an impairment,24,25 and some
adults with CF have taken issue with the way
the condition is presented as an automatic can-
didate for screening.26 Commentators taking a
disability rights perspective have asserted the
need to provide more realistic accounts of life
with a condition provided by those people
most closely aﬀected by them.27
It is increasingly recognized that prenatal
testing information must cover the issues that
people with genetic conditions and their fami-
lies believe to be important28; however, incor-
porating personal experience into information
materials does not necessarily mean that the
end result is ‘balanced’. One web resource
developed speciﬁcally to put the narratives of
those aﬀected by tested-for conditions at the
centre of prenatal testing information material
was evaluated by a range of stakeholders
including those with personal experiences of
the featured conditions.22 In the case of CF, a
group of mothers of aﬀected children did not
feel the personal testimony of the adult with
CF included in the resource captured the varia-
tion in severity of the condition and as such
was unbalanced. The conclusion was that
these narratives counter-balanced the medical
tragedy accounts of genetic conditions, but in
themselves were not balanced.22 This is of con-
cern because ﬁrst-person patient narratives are
popular with people making diﬃcult health-
care choices and are increasingly used in health
information, yet there is some evidence that
this direct use of personal experience may inad-
vertently bias patient decision making in
unpredictable ways.29
To date, development of patient information
using experiential knowledge has used conven-
tional qualitative approaches to capture per-
sonal narrative.30,31 In contrast, we present a
study that used Q-methodology to develop
balanced information about CF for use in
screening information. Q-methodology oﬀers a
promising alternative to developing balanced
information based on experiential knowledge as
it is designed to identify competing viewpoints
on a topic, for example ‘life with CF’.32 Allow-
ing participants to respond to things others
have written or said about CF provides a way
of ‘depersonalizing’ personal accounts. This
may be a useful alternative to the use of ﬁrst-
person narratives, especially as the latter may
be more associated with persuasive eﬀects.29,30
Research aims
In this study, we aimed to utilize the experien-
tial knowledge of adults with CF and parents
of aﬀected children to identify competing
© 2013 John Wiley & Sons Ltd
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viewpoints on which aspects of the condition
they considered most important to include in
prenatal screening information.
Method
The study received ethical approval from a UK
National Health Service Research Ethics Com-
mittee (REC reference number 08/H1306/18).
Designing the Q-set
Q-methodology combines quantitative research
techniques and analysis with qualitative
approaches to sampling and pattern interpreta-
tion.33 The method requires participants to
consider and respond to a set of statements
(the Q-set) extracted from the ‘ﬁeld of shared
knowledge and meaning’ on the topic under
investigation.34 To do this, participants use a
ranking technique (the Q-sort) to allow them
to express their view towards a diverse range
of things already ‘written or said’ about the
topic.32 In this study, a search of the academic
literature was conducted using search terms ini-
tially based on key phrases and words in litera-
ture already identiﬁed. The search terms were
reﬁned throughout the search process as poten-
tial new key terms emerged. Electronic data-
bases, including Psych-Info and Medline were
the main sources of academic literature and the
reference section of relevant papers, were also
hand-searched. Statements were extracted from
papers that addressed personal experiences of
CF, for example, from a QoL perspective. The
search for articles continued until no new state-
ment themes emerged. A search of non-aca-
demic sources (support group websites,
magazines, television programmes and newspa-
pers) was also conducted. It was not our inten-
tion to conduct a comprehensive search of
these sources but just to identify recent and
topical examples of a non-academic perspective
on life with CF. For example, an interview in a
women’s magazine with a woman with CF was
found, and the lead researcher watched a tele-
vision programme about a young English man
with CF. Newspaper articles were searched for
articles on the then Prime Minister of Great
Britain (Gordon Brown), whose son had
recently been revealed to have CF.
In this study, two interviews were conducted
with individuals who had long-term experiences
of CF. The interviews were designed to provide
additional material on themes underrepresented
in the literature, for example, views on the
impact of the condition on schooling and
employment. The ﬁrst interviewee was a parent
of two teenage children with CF who attended
the outpatient service where the study was con-
ducted. The second was an adult with CF who
volunteered after hearing about the study. The
interviews focused on exploring how CF
aﬀected the quality of life of individuals and
family members at key life stages.
From these diﬀerent sources, 154 diﬀerent
statements about CF were extracted. Each
statement was given a primary category under
themes identiﬁed as important during an earlier
review of the literature: lifespan, manageability,
QoL, impact on society.35 Each statement was
given secondary classiﬁcations: (i) according to
whether it broadly represented a medical, psy-
chosocial or social model position on disability,
(ii) whether it had been identiﬁed in academic
or popular literature or an interview, and (iii)
whether it conveyed a positive or negative mes-
sage about CF. For example, the statement
‘Many parents believe CF has made their fam-
ily stronger’ was classiﬁed as belonging to the
primary category QoL and to secondary cate-
gories of: (i) psychosocial model, (ii) academic
literature, and (iii) positive message. A range
of further categories was identiﬁed which
emerged from this process, and these were used
to help reﬁne the 154 items to a short list of 52
for a preliminary Q-set. Three researchers, one
with expertise in Q-methodology, two medical
specialists in CF and a consultant psychologist
reviewed the Q-set. A pilot study was con-
ducted with six individuals, one of whom was
an adult with CF. Following this, some items
were removed from the Q-set and some word-
ing was changed to improve clarity. A ﬁnal Q-
set of 40 items (see Table 1) representing the
original categories was selected.
© 2013 John Wiley & Sons Ltd
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Table 1 Factor arrays (item by ranked position)
F1 F2 F3 F4 F5
1 At first, most parents think they won’t be able to cope with a child with cystic fibrosis
(CF) – but time and again, they find they can
+4 0 2 0 +3
2 Nearly all men with CF are infertile 3 3 3 0 0
3 People can still die very young from CF 0 +5 2 +5 5
4 Modern equipment means that children with CF have a lot more freedom than they
used to and live a more normal life, e.g. they can go on sleepovers
+3 0 +3 +2 +4
5 The typical person with CF is now a fit individual with minimal if any symptoms, who
happens to have a problem called CF
+3 2 0 2 +5
6 Following the introduction of new treatments and better disease management, quality
of life has dramatically improved for people with CF
+3 +1 +5 +4 +1
7 CF can be isolating because of the risk of cross infection from other people with the
condition
0 0 +3 1 1
8 Children with CF undergo numerous treatments, face frequent hospital visits and some
have repeated medical procedures.
+1 +4 0 0 +2
9 Treatment for CF often includes physiotherapy for 20 minutes once or twice a day at
home
+2 +2 +2 +1 +1
10 You can’t know how badly a child will be affected with CF before it is born +1 +4 1 +3 +4
11 Women with CF who get pregnant can experience more problems with their health than
other women
2 1 2 +2 +1
12 Women with CF have greater difficulty getting pregnant 3 4 3 1 3
13 Research suggests mothers of children with CF are more prone to decreased marital
satisfaction and sexual intimacy
4 1 4 3 2
14 Many couples whose first born has CF go on to have other children +2 0 3 3 4
15 Many adults with CF enjoy a good quality of life +4 +2 0 +3 +1
16 It can be difficult for a woman to have career and raise a child with CF 1 +1 0 1 2
17 More than a third of adults with CF are married or living with a partner +2 2 0 1 2
18 People with CF may have to stay in hospital to be given antibiotics intravenously 0 +3 +2 1 1
19 Ultimately lung transplant is often necessary as CF worsens 2 +3 0 +1 +1
20 Many parents believe CF has made their family stronger +2 0 4 3 1
21 Many adults with CF have jobs or study, and are involved in a wide range of professions
and occupations
+2 2 +1 +1 3
22 If people with CF have children, there is a risk that they will be left without a mother
or father
2 1 1 0 0
23 Negative attitudes from others can create extra difficulties for people with CF 3 4 2 3 0
24 As adults with CF get older, they are prone to complications such as diabetes,
liver disease, pneumothorax, osteoporosis, and incontinence
0 +2 3 +2 +2
25 The time and effort spent on the treatment regimen for a child with CF can have an
impact on other family relationships
+1 +3 2 2 0
26 The brothers and sisters of children with CF often feel they are missing out 1 +3 +1 2 +3
27 The improvement in outlook for people with CF has been achieved by increasingly
complex and demanding treatments
0 0 +4 0 +2
28 Up to half of patients with CF currently waiting for a lung transplant will die before a
donor becomes available.
3 +2 +2 +1 1
29 Adolescents with CF whose condition is not severe say they have a good quality of life +3 1 2 +2 0
30 Many people with CF believe it has made them stronger people, and given added
meaning to their lives
+1 3 +1 4 0
31 The improvement in outlook for people with CF has only been achieved by increasingly
expensive treatments, which the NHS is expected to pay for
4 3 3 5 2
32 One challenge for people with CF is managing variability in their health on a daily basis 0 2 +1 +3 +2
33 Gene therapy for CF does not appear to be a realistic option in the near future 2 +1 +3 2 3
34 Half of patients with CF who have a lung transplant are still alive ten years later 1 +1 +1 +3 +2
35 Increasing numbers of women with CF are having children 1 3 2 +2 4
© 2013 John Wiley & Sons Ltd
Health Expectations, 18, pp.1349–1362
Presenting life with cystic fibrosis, K F Wright et al. 1353
Participants
Potential participants (adults with CF or par-
ents of aﬀected children) who were attending
routine outpatient appointment at the regional
CF centre were invited to participate by staﬀ.
Recruitment was carried out over 4 months in
2009 via convenience sampling, that is, during
the time period we aimed to get as many
patients who met the eligibility criteria as pos-
sible. Patients who were signiﬁcantly unwell
were not approached. Response rates were not
recorded but out of those directly approached,
agreement to participate in the research was
high and, subjectively, there did not appear to
be a pattern in terms of who declined, for
example, in terms of socio-economic status.
Sample characteristics were periodically
reviewed to ensure diversity in education, age,
family circumstance and experience of CF. For
example, the parent participants included a
bereaved father, the parent of a teenager who
would need a liver transplant and a mother
whose daughter had such mild symptoms that
she was not diagnosed until she was ten. One
participant with CF had undergone a lung
transplant, and another frequently spent time
in hospital having intravenous antibiotics. In
contrast, one woman had rarely been unwell,
and another had such mild symptoms she had
remained undiagnosed until her mid forties.
Thirty participants carried out a Q-sort: 12
were adults with CF and 18 were parents of
children with CF. Of the parent group, 17 were
mothers with one father. One parent was the
mother of an adult participant and was
recruited via him. Family size ranged from one
to three children; two parents had two children
with CF; several parents had terminated preg-
nancies where the foetus had a diagnosis of
CF. For parents recruited via the children’s
service aﬀected children ranged in age from
8 months to 14 years. Ten parents reported
having left formal education at 18 years or
younger and eight had gone on to higher edu-
cation. Adults with CF (six men, six women)
ranged in age from 23 to 47 years. Nine
reported having left formal education at
18 years or younger, and three had gone on to
higher education. One participant was of South
Asian heritage, and one was of mixed African–
Caribbean heritage. The remainder of the par-
ticipants were White British.
Procedure
Q-sorting took place at the participants’
homes. Informed consent was sought from all
participants. Participants were given a shuﬄed
set of cards (one item per card), which they
sorted according to a verbal instruction to con-
sider which items are most and least important
for pregnant women to take into account when
deciding whether or not to have prenatal
screening for CF. In a series of steps, partici-
pants ranked the items by placing each card in
a cell on a blank grid (see Fig. 1). Each col-
umn of the grid represented a response from
+5 (most important) to 5 (least important).
In this way, a set of ranked data was collected
Table 1. Continued
F1 F2 F3 F4 F5
36 Research shows children and young people with chronic conditions
like CF are much more likely to develop emotional and behavioural
difficulties.
1 2 1 2 4
37 Many treatments, that either target the underlying defect in CF or its
direct consequences, are currently being developed
+1 +1 +3 +1 +3
38 People with CF have to pay just over £100 a year for prescriptions 5 5 +2 4 1
39 Children born with CF now are likely to live well beyond 40 +5 +2 +1 +4 +3
40 Because many people with CF are living longer, they may increasingly
be cared for by their children or partners, rather than their parents
2 1 5 0 3
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for each participant, the pattern of the Q-sort
representing their views about the relative
importance of the items. Participants were
encouraged to make comments on the items,
and these were recorded in a booklet.
Analysis and interpretation
The Q-sort data were managed and analysed
using a Q-software package PQMethod, V.
2.11.36 Q-Methodology uses factor analysis to
32. One 
challenge for 
people with CF 
is managing 
variability in 
their health on a 
daily basis
21. Many 
adults with 
CF have jobs 
or study, and 
are involved 
in a wide 
range of 
professions 
and 
occupations
37. Many 
treatments, 
that either 
target the 
underlying 
defect in CF 
or its direct 
consequences, 
are currently 
being 
developed
27. The 
improvement in 
outlook for 
people with CF 
has been 
achieved by 
increasingly 
complex and 
demanding 
treatments
36. Research 
shows 
children and 
young people 
with CF are 
much more 
likely to 
develop 
emotional and 
behavioural 
difficulties
40. Because 
many 
people with 
CF are 
living 
longer, they 
may 
increasingly 
be cared for 
by their 
children or 
partners, 
rather than 
their parents
29. 
Adolescents 
with CF 
whose 
condition is 
not severe 
say they have 
a good 
quality of life
*20. Many 
parents 
believe CF 
has made 
their family 
stronger
30. Many 
people with 
CF believe it 
has made 
them stronger 
people, and 
given added 
meaning to 
their lives
24. As adults 
with CF get 
older, they are 
prone to 
complications 
such as liver 
disease, 
pneumothorax, 
osteoporosis
and 
incontinence
35. Increasing 
numbers of 
women with 
CF are having
children
33. Gene 
therapy for 
CF does not 
appear to be 
a realistic 
option in the 
near future
28. Up to 
half of 
patients 
with CF 
currently 
waiting 
for a lung 
transplant 
will die 
before a 
donor 
becomes 
available
new 
treatments 
and better 
disease 
management, 
quality of life 
has 
dramatically 
improved for 
people with 
CF
than a third 
of adults 
with CF are 
married or 
living with a 
partner
and effort 
spent on the 
treatment 
regimen for a 
child with CF 
can have an 
impact on 
other family 
relationships
CF may have to 
stay in hospital 
to be given 
antibiotics 
intravenously
patients with 
CF who have 
a lung 
transplant are 
still alive ten 
years later
with CF 
have 
children, 
there is a 
risk that 
they will be 
left without 
a mother or 
father
23. 
Negative 
attitudes 
from 
others can 
create 
extra 
difficultie
s for 
people 
with CF
15. Many 
adults with 
CF enjoy a 
good quality 
of life
5. The 
typical 
person with 
CF is now a 
fit individual 
with minimal 
if any 
symptoms, 
who happens 
to have a 
problem 
called CF
*14. Many 
couples 
whose first 
born has CF 
go on to 
have other 
children
10. You can’t 
know how 
badly a child 
will be 
affected with 
CF before it is 
born
7. CF can be 
isolating 
because of the 
risk of cross 
infection from 
other people 
with the 
condition
26. The 
brothers and 
sisters of 
children with 
CF often feel 
they are 
missing out
19. 
Ultimately 
lung 
transplant is 
often 
necessary as 
CF worsens
12. 
Women 
with CF 
have 
greater 
difficulty 
getting 
pregnant
31. The 
improvement 
in outlook for 
people with 
CF has only 
been achieved 
by expensive 
treatments, 
which the 
NHS have to 
pay for
39. Children 
born with CF 
now are 
likely to live 
well beyond  
40
1. At first, 
most parents 
think they 
won’t be able 
to cope with
a child with 
CF, but time 
and again, 
they find 
they can
4. Modern 
equipment 
means that 
children with 
CF have a lot 
more 
freedom than 
they used to 
and live a 
more normal 
life, e.g. they 
can go on 
sleepovers
9. Treatment 
for CF often 
includes 
physiotherap
y for 20 
minutes once 
or twice a 
day at home
8. Children 
with CF 
undergo 
numerous 
treatments, 
face frequent 
hospital visits 
and some 
have repeated 
medical 
procedures
3. People can 
still die very 
young from CF
16. It can be 
difficult for a 
woman to 
have  career 
and raise a 
child with CF
11. Women 
with CF 
who get 
pregnant 
can 
experience 
more 
problems 
with their 
health than 
other 
women
2. Nearly 
all men 
with CF 
are 
infertile
13. Research 
suggests 
mothers of 
children with 
CF are more 
prone to 
decreased 
marital 
satisfaction 
and sexual 
intimacy
38. People 
with CF have 
to pay just 
over £100 a 
year for  
prescriptions
+5 +4 +3 +2 +1 0 –1 –2 –3 –4 –5
Most important to include in testing information Least important to include in testing information
∗ The placement of items in bold distinguished this factor from all others at p < 0.01
Figure 1 Composite Q-sort for Factor 1. Presenting life with cystic fibrosis as a ‘normal life’.
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identify relationships between individual
Q-sorts. Each factor represents a highly inter-
correlated cluster of Q-sorts sorted in a statisti-
cally similar way. Each cluster is considered to
represent a distinct point of view on the given
topic. Using the strategy described by Watts
and Stenner,33 and using PCA and Varimax
rotation, a ﬁve-factor solution was identiﬁed as
the ‘best ﬁt’ for the data, that is, the maximum
number of interpretable and distinct view-
points. Each of the factors had at least two Q-
sorts loading highly and at P < 0.01 on one
factor only (known as exemplar sorts). Table 2
provides information on the participants whose
Q-sorts were exemplars of each factor. A
weighted averaging formula was used to pro-
duce an ‘average’ composite Q-sort from the
exemplar sort to represent each factor (see
Table 1).37 These composite sorts were recon-
structed on grids to support interpretation; for
example, Fig. 1 represents the composite Q-
sort for Factor 1. During interpretation, partic-
ular attention was given to the position of the
‘most important’ and ‘least important’ items
and the statements identiﬁed as statistically dis-
tinguishing for each factor at P < 0.01.
Findings
A description of each factor is now presented.
The comments provided by participants were
used to inform, support or challenge factor
interpretations, and these are presented where
they clarify the interpretation. For each factor,
a label summarizes the central message of the
viewpoint.
Factor 1: ‘Presenting life with CF as a normal
life’
The central message of this factor was that life
with CF is essentially a normal one. Partici-
pants considered Item 39 (children born with
CF now are likely to live well beyond 40 years)
as the most important thing that prospective
parents should know. Other items considered
important were those that emphasized the
probability of a good quality of life for the
person with CF and their parents, the ability
of parents to cope and normal life experiences
including relationships and children for those
with CF. The placement of Items 14, 17 and 20
(see Table 1) statistically distinguished this fac-
tor from all others. Unlike any other factor,
Factor 1 participants agreed it is important to
convey that having a child with CF can
strengthen a family. A mother with two chil-
dren with CF said, ‘I think it’s important for
people to know it’s not all doom and gloom. A
lot of it is down to attitude and being positive
and not always fearing the worst’.
Participants gave a low priority to informa-
tion about the possible negative long-term con-
sequences of CF, for example infertility or the
potential need for a lung transplant. Neverthe-
less, they agreed that information about the
‘burden’ of treatments was still important
(Items 8, 9 and 25). The ﬁnancial costs of CF
to the individual and the UK National Health
Table 2 Characteristics of participants whose Q-sorts exemplified each factor
Adults with CF Parents of children with CF
Factor 1 A woman in her late thirties and a man in his early
forties. Both described themselves as being in
good health.
One mother with two children with CF. One father with a
child with CF and a previous child with CF who had died.
Five mothers who had one child with CF and at least one
other child without CF
Factor 2 Four mothers, each with one child with CF and one child
without CF
Factor 3 A woman in her early twenties who had undergone
a lung transplant
A mother of a baby with CF and an older child without CF
Factor 4 Three men and one woman with CF in their twenties
Factor 5 A woman with CF in her mid thirties A mother of a 10 year old child with CF and two other
children without CF.
© 2013 John Wiley & Sons Ltd
Health Expectations, 18, pp.1349–1362
Presenting life with cystic fibrosis, K F Wright et al.1356
Service were considered least important to
include along with information that mothers of
aﬀected children may experience lowered mari-
tal satisfaction.
Factor 2: ‘Presenting CF as a serious threat to
health, happiness and a normal life’
The central message of Factor 2 was that CF
is a serious life-threatening health condition
with major implications for the individual and
their family. As in Factor 1, participants con-
sidered information about lifespan as the most
important to convey to prospective parents but
in contrast selected Item 3 (people can still die
very young from CF) as the ‘most important’.
As one mother said, ‘That’s the ﬁrst thing you
think about. You deﬁnitely need to know that’.
The potential for living beyond 40 years was
considered to be lower priority (Item 39) for
this factor.
Other important items were those conﬁrming
the diﬃculty of predicting severity and that the
burden of treatments on the individual and
their family can be signiﬁcant. A mother of a
young child with CF said, ‘Treatment takes so
much time up…. Hospital takes over your life:
it’s majorly important’. In this view, it is more
important to present information about the
immediate life diﬃculties of the child rather
than the (potential) future life as a teenager or
adult. The placement of Items 16 and 25 distin-
guished this factor statistically demonstrating
the view that the impact of CF on the family,
and especially the mother, should be taken into
consideration by those considering screening.
Participants did not agree that CF makes peo-
ple or families stronger. Items that portray life
with CF as diﬃcult were prioritized over posi-
tive aspects. As the mother of a young child
with CF said, ‘You don’t just want to put all the
good points as most important, because other-
wise you’re encouraging people to have kids with
CF when they don’t know how bad it is’.
Factor 3: ‘Presenting quality of life with CF as
dependent on medical intervention’
The main message of Factor 3 was that for
people with CF, a ‘normal’ life was likely to be
one highly dependent on a regimen of medica-
tions and therapies and that health services
had a very important role in upholding the
QoL of an aﬀected individual. Participants
placed little importance on information about
family adjustment and coping, impact on per-
sonal relationships or the long-term negative
consequences of CF.
The placement of Items 31 and 38 statisti-
cally distinguished this factor and emphasized
the possible ﬁnancial implications of CF, for
example, prescription charges. The woman
with CF said, ‘very important, because people
can’t really aﬀord it’. Some diﬃculties, such as
women trying to have a career while raising an
aﬀected child, were also seen as being due to a
lack of social support. For example, in
response to Item 16, the mother of the baby
with CF said, ‘True. I was going back to work,
but now it’s absolutely impossible, you can’t
work round it. It’s very important [to know],
because I feel there’s no help or support’.
Factor 4: ‘Presenting CF from the life-course
perspective’
Exemplars of this factor were all adults with
CF and most strongly emphasized the need for
information to convey the longer-term view of
life with the condition. Items considered impor-
tant to include balanced the possibility of an
early death with the potential for a longer,
good quality life and possibilities for parent-
hood. The need to convey information about
the range in severity and variability of health
was also emphasized.
This factor was distinguished from all the
others by the high rating of information about
the fertility and parenthood prospects of the
person with CF (Items 2, 11, 12, 35, 40). Com-
ments suggested that participants wanted infor-
mation to capture a ‘life’ with CF, not just
discrete problems. One man with CF said, ‘It’s
like anything, there are good times and bad
times’. Assumptions about the burden of treat-
ment were not always supported. One man
said, ‘I quite like going into hospital. It’s time
oﬀ work and a nice holiday. I like peace and
quiet – they leave me alone’. Factor 4 most
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strongly rejected the idea that parents should
be told CF makes people stronger or adds
meaning to their lives.
Factor 5: ‘Presenting life with CF as one of
adjustment and living in the present’
The central message was that while the severity
of CF cannot always be known in advance and
health will vary over time, most parents and
aﬀected individuals adjust and cope (Items 10,
4 and 5). The woman participant with CF said,
‘If you decide to have a child, you take what
comes’. Higher priority was given to presenting
positive information and to demonstrating that
people with CF can be healthy. This factor
emphasized the importance of living in the
present and the fact that some people aﬀected
with CF can still die very young was consid-
ered least important to convey. One mother
said, ‘I don’t know [what will happen in the
future] and I don’t want to think about it’.
Including information about the potential
for people with CF to have a partner, a job
and children was seen as a low priority. Low
priority was also given to the possible impact
on a mother’s career and the fact that many
couples with an aﬀected child will subsequently
have non-aﬀected children.
Discussion
This study aimed to identify competing view-
points on the aspects of CF that those with
personal experience of the condition consid-
ered most important to include in prenatal
screening information. Although the main
focus of the task was on information develop-
ment, the ﬁndings reﬂect previous work show-
ing that those with outwardly similar
experiences can have very diﬀerent perspectives
on life with the same condition.38 Personal
factors, including CF related experiences, dis-
ease severity and family resources may, for
example, have inﬂuenced the viewpoints
expressed and may help explain the conﬂicting
views of Factors 1 and 2, and the concerns
about ﬁnancial and social support in Factor 3.
All the participants with CF had survived to
adulthood, which may underlie their more
‘future focused’ views and the need to ‘live in
the present’ as expressed in Factors 4 and 5.
In-depth interviews were not conducted, how-
ever, in the initial short background inter-
views, participants across all factors reported a
wide range in problems and experiences. It is
unlikely that viewpoints were solely related to
speciﬁc life experiences or severity of the con-
dition per se. For example, the mothers who
were exemplars of Factor 2 reported signiﬁ-
cant health problems in their children, but
some Factor 1 exemplars had experienced CF
related bereavement and similar diﬃcult health
challenges. In support of this view, a review of
studies investigating adaptation to living with
genetic conditions, including CF, suggested
that disease severity is less related to successful
adaptation of parents or individuals than eﬀec-
tive coping strategies. 39 However, the Q-sorts
represent a snapshot in time. One parent, an
exemplar of Factor 1, said, ‘When [son] was
diagnosed, they said he’d have a port-a-cath and
be in hospital every 3 months. I’d have answered
very diﬀerently then’. The severity of CF is
therefore not a static characteristic of the
disease and ability to cope may also ﬂuctuate
over time. In addition, as new treatments are
developed the outlook for some children born
with CF may dramatically improve. This
highlights the need to regularly revisit condi-
tion-related information in prenatal testing
materials.
This research highlights once more the chal-
lenge of portraying a complex genetic condition
like CF in a way that can be considered ‘bal-
anced’ by all interested parties. Opinions on
what represented the most and least important
information to include in prenatal screening
information about CF varied considerably
across accounts. Although CF is considered a
serious life-shortening condition, some partici-
pants expressed conﬂict or uncertainty when
considering where to place some of the ‘nega-
tive’ items of information on the Q-grid. For
example, in relation to Item 19, a participant
with CF in Factor 1 said, ‘They do need to know
the full picture [about lung transplantation]…
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but why mention it at this moment in time?’ In
response to Item 40 a woman with CF said, ‘I
think that’s true [that partners or children may
become carers of those with CF] but I wouldn’t
want it to put people oﬀ.’ These participants
may have considered these items as too
abstract or long-term to be relevant at the pre-
natal screening stage. Alternatively, it may be
diﬃcult for those for whom coping with CF
means living in the present and ‘being positive’
to want to include rather negative, long-term
aspects of the condition in prenatal screening
information.
In contrast to the arguments already pre-
sented that chronic illness and disability have
been too negatively portrayed in prenatal test-
ing information, it has also been suggested that
the use of personal accounts leads to an overly
positive representation of serious health prob-
lems.22 As already identiﬁed, one person’s per-
ception of balance is another’s bias and so
subjective assessments of this kind have limited
value. However, for a balance of perspectives
to be present, the views of those who consider
‘negative’ information about a condition to be
important need to be valued equally with the
views of those whose who preference a more
‘positive’ view. While many parents successfully
adapt to having a child with a disability or
genetic condition not all do, and this is an
important factor to consider when trying to
utilize a range of experiences in prenatal testing
information development.39
We employed Q-methodology speciﬁcally
because it helps identify competing viewpoints
on complex issues and provides a more objec-
tive approach to the selection of experience-
based material to include in prenatal screening
information. Clearly deﬁning the constituent
elements of separate and sometimes conﬂicting
views of CF is important for the development
of a balanced portrayal. Nevertheless, from a
practical perspective, integrating contradictory
viewpoints into health resources presents a
challenge: we suggest three ways in which the
ﬁndings obtained using Q-methodology could
be employed in the development of prenatal
screening information.
1. The creation of third-person narratives One
approach to using the ﬁndings of a Q-study
would be to construct a set of short third-
person accounts based on the individual fac-
tors. Presenting separate accounts may help
parents clarify their own values as they con-
sider which perspectives they most identify
with and those they reject.30
2. Using factor exemplars to select interviewees
Where the use of ﬁrst-person narratives is
required or preferred, an evidence-based
rationale for interviewee sampling would be
to select individuals who were factor exemp-
lars across the range of views.
3. Integrating factors to create a balanced sum-
mary Another option would be to create a
single integrated account to represent a
range of diﬀering views. For example, in
this study, if all items ranked +5 and +4
across the diﬀerent factors were integrated,
the summary for CF would read something
like this:
‘People with CF can have a high quality of life
but the degree to which a person will be
aﬀected cannot always be predicted before
birth. A baby born today with CF is likely to
live well into adulthood, but some will die in
childhood. Modern treatment means that
aﬀected children have more freedom than they
used to and live a more normal life. Medical
advances mean people with CF can live
healthier lives, but children and adults often
require ongoing treatments, frequent hospital
visits and medical procedures. These treat-
ments can be complicated and are experienced
as demanding by some parents and children.
Many parents ﬁnd that they can cope with a
child with CF better than they might have
expected, but some parents do not.’
The advantage of the third approach would
be that conﬂicting viewpoints are integrated in
a way that is familiar to many users of health
information. However, the selected content
would be underpinned by research evidence
and would represent the experiential knowledge
of those who have a diverse range of exp-
eriences and diﬀering perspectives. Such a
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summary could be presented in written format
as part of a leaﬂet or website, or communi-
cated verbally in addition to traditional general
facts information based on medical and clinical
evidence, which is also valued by prospective
parents.30 Other key stakeholders, for example,
health-care providers and patient support orga-
nizations should therefore be included in the
development of test information.
This study had some limitations. Although
the experience of participants varied according
to disease severity, family economic circum-
stances and experiences of bereavement, all
participants used the same CF services. We did
not include children or people with CF who
were signiﬁcantly unwell; their viewpoints may
be diﬀerent from those expressed in this study.
Only one father participated; therefore, paren-
tal reviews mainly reﬂected those of mothers.
It is also important to recognize that parents
vary in their information requirements at dif-
ferent stages of the testing pathway. This study
required participants to consider information
for prenatal screening only. We acknowledge
the important diﬀerences between screening
and invasive diagnostic tests and that more
detailed information about health-related
implications, for example, may be of beneﬁt to
parents at the diagnostic decision-making
stage. Finally, this study focused on prenatal
testing, something which is inextricably linked
with termination of pregnancy. Pre-conceptual
testing for CF carrier status is available, and it
may be more appropriate for some couples
than testing during pregnancy; it is possible
that participants may have prioritized some
items diﬀerently if the development of pre-
conception testing information had been the aim.
Conclusion
There are currently no guidelines on how to
develop balanced, condition-related informa-
tion within prenatal or other genetic testing
information. Research suggests that when
delivering information about conditions, health
professionals select the information to convey;
inevitably therefore, judgments about what
constitutes balanced information remains with
the individual professional.23,40 Where the sup-
port of autonomous informed choice is a goal,
parents making important reproductive deci-
sions should be able to access information that
supports a range of viewpoints. There is a need
for more systematic and objective approaches
to the development of this kind of information,
and we have argued that Q-methodology pro-
vides one such approach. In particular, the
strength of applying Q-methodology to this
problem lies in its original premise that all
diverse viewpoints on a socially debated topic
are equally valid. Using Q-methodology in the
ways we suggest here may help the develop-
ment of information materials that better sup-
port prenatal testing decisions for CF. While it
is recognized that the application of Q-method-
ology to developing health information is novel
and needs further reﬁnement, we believe it has
the potential to make a signiﬁcant contribution
beyond the prenatal screening context.
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